This inventor holds 1 USPTO granted patent. Top assignee: Anthera Pharmaceuticals, Inc.. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Certainly! Here is an article about inventor Kenneth Gould:
Title: Innovator Spotlight: Kenneth Gould Revolutionizes Treatment for Cardiovascular Disease
Introduction: Kenneth Gould, a distinguished inventor based in Zionsville, IN, has made groundbreaking contributions to the field of cardiovascular disease (CVD) treatment through his innovative patents. With a keen focus on addressing dyslipidemia, atherosclerosis, and metabolic syndrome, Gould's inventions are shaping the future of medical interventions for these conditions.
Latest Patents: One of Gould's notable patents involves the administration of sPLA2 inhibitors, which have shown promising results in decreasing cholesterol levels, atherosclerotic plaque formation, and aortic aneurysm. His method of using sPLA2 inhibitors in conjunction with compounds like statins has demonstrated a synergistic effect in reducing LDL and LDL particle levels, as well as plaque content.
Career Highlights: Currently affiliated with Anthera Pharmaceuticals, Inc., Kenneth Gould continues to pioneer advancements in cardiovascular healthcare. His dedication to developing innovative treatment methods underscores his commitment to improving patient outcomes and addressing critical cardiology challenges.
Collaborations: In his professional journey, Kenneth Gould has collaborated with esteemed colleagues such as Joaquim Trias and Colin Hislop. Together, they have combined their expertise to push the boundaries of CVD treatment and explore new avenues for combating heart-related ailments.
Conclusion: Kenneth Gould's inventive spirit and tireless efforts in the realm of cardiovascular disease management have positioned him as a leading figure in the field. His patents and collaborations stand as a testament to his commitment to driving innovation and making a tangible difference in the lives of individuals affected by CVD. With his relentless pursuit of excellence, Gould continues to inspire the future of cardiology and pave the way for transformative healthcare solutions.
Please let me know if you need any more information or if there are any specific details you would like to add or modify in the article!
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile